ArticleJournal of biomedical optics2026
SEFCA-Net: a semantic-edge-frequency cross-attention network for diabetic retinopathy lesion segmentation.
Article in Journal of biomedical optics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Diabetic retinopathy (DR) lesion segmentation provides pixel-level lesion localization in fundus images. However, such lesions are often tiny, sparsely distributed, low-contrast, morphologically diverse, and visually similar to vessels or surrounding retinal structures, making accurate localization difficult. Many existing methods emphasize multi-scale spatial representation learning and handle boundary ambiguity and subtle texture differences mainly through encoder-decoder fusion. We therefore examine boundary and frequency representations as explicit, complementary inputs to semantic decoding. Aim: We aim to develop SEFCA-Net, a semantic-edge-frequency cross-attention network for diabetic retinopathy lesion segmentation. The main objective is to examine whether semantic, edge, and frequency-domain representations can be fused under semantic guidance to improve pixel-level lesion localization without compromising the semantic decoding stream. The evaluation focuses on four lesion categories, including hard exudates, hemorrhages, soft exudates, and microaneurysms, using public benchmarks and a DDR-to-IDRiD cross-dataset setting. Approach: SEFCA-Net uses HRNet-W48 as the semantic backbone to extract multi-scale semantic features and explicitly constructs edge and frequency-domain representations from input fundus images. The learnable multi-scale edge branch extracts boundary-sensitive features, while the all-channel multi-scale discrete cosine transform (DCT) frequency-domain branch generates texture-sensitive responses to low-contrast lesions. The semantic-edge-frequency cross-attention decoder uses the semantic representation as the primary stream and injects edge and frequency-domain features through semantic-guided window-based cross-attention. Performance is evaluated using the area under the precision-recall curve (AUPR), Dice, and Intersection-over-Union (IoU). Results: On DDR, SEFCA-Net achieves 47.85% mean AUPR (mAUPR), 46.76% mean Dice, and 31.22% mean IoU. On IDRiD, it reaches 69.74% mAUPR; when trained on DDR and tested on IDRiD, it obtains 59.83% mAUPR. Ablation studies show that either auxiliary branch improves the semantic-only baseline and that the complete configuration gives the highest mAUPR. Multi-scale Sobel modeling and DCT outperform the tested single-scale and wavelet alternatives, respectively. Conclusions: SEFCA-Net shows that semantic features can remain the main decoding stream while boundary-sensitive features and texture-sensitive responses are integrated in a controlled manner. Under the evaluated protocols, the model shows competitive in-domain performance and records the highest DDR-to-IDRiD mAUPR among the reproduced methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.